- Home
- AHR vs TMDX Comparison
AHR vs TMDX Comparison
Compare AHR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHR
- TMDX
- Stock Information
- Founded
- AHR 2013
- TMDX 1998
- Country
- AHR United States
- TMDX United States
- Employees
- AHR N/A
- TMDX N/A
- Industry
- AHR
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AHR
- TMDX Health Care
- Exchange
- AHR NYSE
- TMDX Nasdaq
- Market Cap
- AHR 5.2B
- TMDX 4.8B
- IPO Year
- AHR 2024
- TMDX 2019
- Fundamental
- Price
- AHR $36.48
- TMDX $130.82
- Analyst Decision
- AHR Strong Buy
- TMDX Buy
- Analyst Count
- AHR 8
- TMDX 10
- Target Price
- AHR $37.75
- TMDX $127.33
- AVG Volume (30 Days)
- AHR 1.9M
- TMDX 843.5K
- Earning Date
- AHR 08-04-2025
- TMDX 07-30-2025
- Dividend Yield
- AHR 2.72%
- TMDX N/A
- EPS Growth
- AHR N/A
- TMDX N/A
- EPS
- AHR N/A
- TMDX 1.41
- Revenue
- AHR $2,104,227,000.00
- TMDX $488,227,000.00
- Revenue This Year
- AHR $8.10
- TMDX $34.07
- Revenue Next Year
- AHR $6.50
- TMDX $20.76
- P/E Ratio
- AHR N/A
- TMDX $95.36
- Revenue Growth
- AHR 10.53
- TMDX 64.43
- 52 Week Low
- AHR $14.41
- TMDX $55.00
- 52 Week High
- AHR $36.96
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- AHR 57.41
- TMDX 53.46
- Support Level
- AHR $35.46
- TMDX $120.36
- Resistance Level
- AHR $36.83
- TMDX $133.49
- Average True Range (ATR)
- AHR 0.89
- TMDX 5.52
- MACD
- AHR -0.07
- TMDX -2.21
- Stochastic Oscillator
- AHR 46.19
- TMDX 39.34
About AHR AMERICAN HEALTHCARE REIT INC
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.